Misoprostol

The study compiled complaints made to the New Orleans Health Department and found regular delays for various reasons in accessing misoprostol.

Republican lawmakers in Kentucky, Missouri and Texas introduced similar legislation to Louisiana's law that reclassified mifepristone and misoprostol as Schedule IV controlled substances.